Literature DB >> 1091567

On the question of permeability of the blood-brain barrier to botulinum toxin.

D A Boroff, G S Chen.   

Abstract

The clinical symptoms of botulinum intoxication suggest that besides the involvement of the peripheral nervous system, the central nervous system is also affected. Studies were undertaken to determine whether pure toxin of Clostridium botulinum type A could be demonstrated in the brains of poisoned mice. With the aid of autoradiography of the toxin marked with 125-I and indirect fluorescent labeling it was possible to show the presence of the toxin in the parenchyma of the brain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091567     DOI: 10.1159/000231337

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  12 in total

Review 1.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 2.  Neurophysiological effects of botulinum toxin type A.

Authors:  G Abbruzzese; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 3.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

Review 4.  Botulinum toxin injection of eye muscles to correct strabismus.

Authors:  A B Scott
Journal:  Trans Am Ophthalmol Soc       Date:  1981

Review 5.  Botulinum toxin type A therapy for cervical dystonia.

Authors:  Mafalda Castelão; Raquel E Marques; Gonçalo S Duarte; Filipe B Rodrigues; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2017-12-12

Review 6.  Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Authors:  Gonçalo S Duarte; Mafalda Castelão; Filipe B Rodrigues; Raquel E Marques; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-26

Review 7.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

8.  Botulinum toxin type A therapy for blepharospasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Raquel E Marques; Mafalda Castelão; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

9.  Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.

Authors:  Maja Kojovic; Antonio Caronni; Matteo Bologna; John C Rothwell; Kailash P Bhatia; Mark J Edwards
Journal:  Mov Disord       Date:  2011-04-05       Impact factor: 10.338

Review 10.  Botulinum toxin for motor and phonic tics in Tourette's syndrome.

Authors:  Sanjay Pandey; Prachaya Srivanitchapoom; Richard Kirubakaran; Brian D Berman
Journal:  Cochrane Database Syst Rev       Date:  2018-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.